Is There Room for Immune Checkpoint Inhibitors in Patients Who Have NSCLC With Autoimmune Diseases?

Jordi Remon, Lizza Hendriks, Sandrine Aspeslagh, Benjamin Besse*

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Pages (from-to)1701-1703
Number of pages3
JournalJournal of Thoracic Oncology
Volume14
Issue number10
DOIs
Publication statusPublished - Oct 2019

Keywords

  • LUNG-CANCER
  • EFFICACY
  • SAFETY

Cite this